• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ZC3H7B-BCOR 融合型高级别子宫内膜间质肉瘤,伴低级别子宫内膜间质肉瘤形态学特征。病例报告及文献复习。

ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.

出版信息

Int J Gynecol Pathol. 2023 Nov 1;42(6):597-601. doi: 10.1097/PGP.0000000000000917. Epub 2023 Aug 10.

DOI:10.1097/PGP.0000000000000917
PMID:37562066
Abstract

High-grade endometrial stromal sarcomas with ZC3H7B-BCOR fusion are rare. They are predominantly located in the endomyometrium, with morphologic features characterized as haphazardly arranged fascicles of spindle cells with mild to moderate atypia, abundant myxoid matrix, high mitotic index, and tongue-like/pushing patterns of myometrial invasion. Furthermore, conventional or variant low-grade endometrial stromal sarcomas are often not present. Clinically, they present at a higher stage and are associated with worse prognosis compared with low-grade endometrial stromal sarcoma. Given the limited number of reported cases, we describe the case of a ZC3H7B-BCOR fusion high-grade endometrial stromal sarcoma initially diagnosed on the hysterectomy specimen as low-grade endometrial stromal sarcoma based on an endometrial stromal tumor showing tongue-like myometrial and lymphovascular invasion, minimal cytologic atypia, low-mitotic activity (0-1/10 high-power field), round/spindle cell component and immunohistochemical stain results (positive for CD10, estrogen receptor, progesterone receptor, and focally positive for cyclin D1). At the time of pathologic diagnosis, she was Stage Ia and managed conservatively. Subsequent molecular analysis revealed a ZC3H7B (exon 10)- BCOR (BCL-6 corepressor) (exon 7) gene fusion. On follow-up, she showed no evidence of disease at 37 months from the time of diagnosis. This case report expands the morphologic spectrum of ZC3H7B-BCOR fusion high-grade ESS, which includes an intramural location, morphologic and immunophenotypic features similar to LG-ESS, as well as the presence of round and spindle cell components. This case also underscores the value of molecular analysis in the proper classification of ESS.

摘要

具有 ZC3H7B-BCOR 融合的高级子宫内膜间质肉瘤较为罕见。它们主要位于子宫肌内,形态学特征表现为随意排列的梭形细胞束,具有轻度至中度异型性、丰富的黏液样基质、高有丝分裂指数和舌状/推进性的子宫肌侵犯模式。此外,通常不存在传统或变体低度子宫内膜间质肉瘤。与低度子宫内膜间质肉瘤相比,它们在临床上表现为更高的分期,并与更差的预后相关。鉴于报道的病例数量有限,我们描述了一例 ZC3H7B-BCOR 融合的高级子宫内膜间质肉瘤,最初在子宫切除标本中根据子宫内膜间质肿瘤表现为舌状子宫肌和血管侵犯、最小的细胞学异型性、低有丝分裂活性(0-1/10 高倍视野)、圆形/梭形细胞成分和免疫组织化学染色结果(CD10、雌激素受体、孕激素受体阳性,cyclin D1 局灶阳性)诊断为低度子宫内膜间质肉瘤。在病理诊断时,她处于 Ia 期并接受保守治疗。随后的分子分析显示 ZC3H7B(外显子 10)-BCOR(BCL-6 核心抑制因子)(外显子 7)基因融合。在随访中,从诊断时起 37 个月后她没有疾病证据。该病例报告扩展了 ZC3H7B-BCOR 融合高级 ESS 的形态学谱,包括腔内位置、形态和免疫表型特征与 LG-ESS 相似,以及存在圆形和梭形细胞成分。该病例还强调了分子分析在正确分类 ESS 中的价值。

相似文献

1
ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.ZC3H7B-BCOR 融合型高级别子宫内膜间质肉瘤,伴低级别子宫内膜间质肉瘤形态学特征。病例报告及文献复习。
Int J Gynecol Pathol. 2023 Nov 1;42(6):597-601. doi: 10.1097/PGP.0000000000000917. Epub 2023 Aug 10.
2
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.ZC3H7B-BCOR 高级别子宫内膜间质肉瘤:一种新定义实体的 17 例报告。
Mod Pathol. 2018 Apr;31(4):674-684. doi: 10.1038/modpathol.2017.162. Epub 2017 Dec 1.
3
ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification?ZC3H7B-BCOR 重排型子宫内膜间质肉瘤:一个独特的亚类值得单独分类吗?
Int J Gynecol Pathol. 2019 Sep;38(5):420-425. doi: 10.1097/PGP.0000000000000523.
4
An Unusual Endometrial Stromal Neoplasm With JAZF1-BCORL1 Rearrangement.一种伴有JAZF1-BCORL1重排的罕见子宫内膜间质肿瘤。
Int J Gynecol Pathol. 2024 Jan 1;43(1):33-40. doi: 10.1097/PGP.0000000000000941. Epub 2023 Jan 23.
5
Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.具有 BCOR 内串联重复和变异 BCOR/BCORL1 重排的子宫内膜间质肉瘤类似于具有反复 CDK4 通路改变和 MDM2 扩增的高级别子宫内膜间质肉瘤。
Am J Surg Pathol. 2022 Aug 1;46(8):1142-1152. doi: 10.1097/PAS.0000000000001909. Epub 2022 May 3.
6
JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.原发性子宫外低级别和高级别子宫内膜间质肉瘤中 JAZF1、YWHAE 和 BCOR 基因易位。
Histopathology. 2022 Apr;80(5):809-819. doi: 10.1111/his.14608. Epub 2022 Feb 7.
7
Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.BCOR 重排的高级别子宫内膜间质肉瘤(HG-ESS)的乳腺转移:一个新转移部位的病例报告。
Diagn Pathol. 2023 Mar 2;18(1):34. doi: 10.1186/s13000-023-01313-z.
8
Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series.147例低级别子宫内膜间质肉瘤的免疫组织化学分析:在一个经分子学确认的大样本系列中完善LG-ESS的免疫组织化学特征
Virchows Arch. 2025 Jan 21. doi: 10.1007/s00428-025-04026-4.
9
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.BCOR 是一种强有力的诊断免疫组化标志物,可用于多种遗传学上不同的高级别子宫内膜间质肉瘤,包括具有变异形态的肿瘤。
Mod Pathol. 2017 Sep;30(9):1251-1261. doi: 10.1038/modpathol.2017.42. Epub 2017 Jun 16.
10
Aggressive High-grade Uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis.具有 MEIS1-NCOA2 融合和多个 12q13-15 基因扩增的侵袭性高级别子宫肉瘤:形态学、免疫组织化学和分子分析的一例报告。
Int J Gynecol Pathol. 2023 Sep 1;42(5):460-465. doi: 10.1097/PGP.0000000000000937. Epub 2023 Jan 25.

引用本文的文献

1
BCOR abnormalities in endometrial stromal sarcoma.子宫内膜间质肉瘤中的BCOR异常
Gynecol Oncol Rep. 2025 Jan 7;57:101672. doi: 10.1016/j.gore.2024.101672. eCollection 2025 Feb.